Stocks
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -9.35 | 15.1 | -8.33 | -3.31 | -11.9 | -8.31 | ||
| Changes by years, y/y, % | +17% | -261% | -155% | -60% | +260% | +8.4% | |||
Blueprint Medicines Corporation. EV/EBITDA
Blueprint Medicines Corporation. EV/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -3.37 | -5.93 | -4.43 | -11.7 | -13.3 | -8.31 | |
| Changes by years, y/y, % | -35% | +81% | +1% | +250% | +295% | |||
| Changes by quarters, q/q, % | +1% | +76% | -25% | +165% | +14% | |||
